| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $3,211,486 | 21 | 100 |
| Leupin Nicolas | Former Chief Medical Officer | 0 | $0 | 1 | $14,636 | $-14,636 |
| Puri Michal Nath | Chief Human Resources Officer | 0 | $0 | 2 | $34,325 | $-34,325 |
| HILLEMAN JERYL L | director | 0 | $0 | 1 | $46,445 | $-46,445 |
| Hung David | director | 0 | $0 | 1 | $46,445 | $-46,445 |
| LEUNG GABRIEL | director | 0 | $0 | 1 | $46,445 | $-46,445 |
| Ocean Allyson J | director | 0 | $0 | 1 | $46,445 | $-46,445 |
| Scannell Timothy J | director | 0 | $0 | 1 | $46,445 | $-46,445 |
| Stafford Kristin | director | 0 | $0 | 1 | $46,445 | $-46,445 |
| VERNON W ANTHONY | director | 0 | $0 | 1 | $46,445 | $-46,445 |
| Brackmann Christoph | Chief Financial Officer | 0 | $0 | 1 | $85,314 | $-85,314 |
| Weinberg Uri | Chf Medical and Innovation Ofr | 0 | $0 | 3 | $232,178 | $-232,178 |
| Paravasthu Mukund | Chief Operating Officer | 0 | $0 | 2 | $667,214 | $-667,214 |
| Leonard Frank X | Chief Executive Officer | 0 | $0 | 4 | $919,823 | $-919,823 |
| DOYLE WILLIAM F | Executive Chairman | 0 | $0 | 1 | $932,883 | $-932,883 |
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax. The company also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure …
Over the last 12 months, insiders at Novocure Ltd have bought $0 and sold $3.21M worth of Novocure Ltd stock.
On average, over the past 5 years, insiders at Novocure Ltd have bought $869,099 and sold $8.88M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 81,550 shares for transaction amount of $996,859 was made by Cordova Ashley (Chief Executive Officer) on 2025‑09‑05.
| 2026-06-04 | Sale | Leonard Frank X | Chief Executive Officer | 34,273 0.0295% | $17.93 | $614,635 | -10.56% | |
| 2026-06-02 | Sale | VERNON W ANTHONY | director | 2,945 0.0025% | $15.77 | $46,445 | +2.09% | |
| 2026-06-02 | Sale | LEUNG GABRIEL | director | 2,945 0.0025% | $15.77 | $46,445 | +2.09% | |
| 2026-06-02 | Sale | Hung David | director | 2,945 0.0025% | $15.77 | $46,445 | +2.09% | |
| 2026-06-02 | Sale | Scannell Timothy J | director | 2,945 0.0025% | $15.77 | $46,445 | +2.09% | |
| 2026-06-02 | Sale | HILLEMAN JERYL L | director | 2,945 0.0025% | $15.77 | $46,445 | +2.09% | |
| 2026-06-02 | Sale | Stafford Kristin | director | 2,945 0.0025% | $15.77 | $46,445 | +2.09% | |
| 2026-06-02 | Sale | Ocean Allyson J | director | 2,945 0.0025% | $15.77 | $46,445 | +2.09% | |
| 2026-03-05 | Sale | Paravasthu Mukund | Chief Operating Officer | 43,246 0.0374% | $13.77 | $595,670 | +11.45% | |
| 2026-03-04 | Sale | Leonard Frank X | Chief Executive Officer | 5,607 0.005% | $13.31 | $74,603 | +18.03% | |
| 2026-03-04 | Sale | Weinberg Uri | Chf Medical and Innovation Ofr | 6,412 0.0057% | $13.31 | $85,314 | +18.03% | |
| 2026-03-04 | Sale | Puri Michal Nath | Chief Human Resources Officer | 1,100 0.001% | $13.31 | $14,636 | +18.03% | |
| 2026-03-04 | Sale | Brackmann Christoph | Chief Financial Officer | 6,412 0.0057% | $13.31 | $85,314 | +18.03% | |
| 2026-03-04 | Sale | Paravasthu Mukund | Chief Operating Officer | 5,377 0.0048% | $13.31 | $71,543 | +18.03% | |
| 2026-03-04 | Sale | Leupin Nicolas | Former Chief Medical Officer | 1,100 0.001% | $13.31 | $14,636 | +18.03% | |
| 2026-03-03 | Sale | DOYLE WILLIAM F | Executive Chairman | 71,887 0.0616% | $12.98 | $932,883 | +19.06% | |
| 2026-03-02 | Sale | Leonard Frank X | Chief Executive Officer | 7,232 0.0064% | $13.49 | $97,581 | +17.09% | |
| 2026-03-02 | Sale | Weinberg Uri | Chf Medical and Innovation Ofr | 3,272 0.0028% | $13.33 | $43,607 | +17.09% | |
| 2026-02-27 | Sale | Leonard Frank X | Chief Executive Officer | 9,734 0.0087% | $13.66 | $133,003 | +15.76% | |
| 2026-02-27 | Sale | Weinberg Uri | Chf Medical and Innovation Ofr | 7,461 0.0067% | $13.84 | $103,257 | +15.76% |
| Brackmann Christoph | Chief Financial Officer | 182842 0.1564% | $2.46M | 1 | 1 | +13.53% |
| Perlhagen Gert L. | director | 6125000 5.2388% | $82.26M | 1 | 1 | +171.79% |
| Cordova Ashley | Chief Executive Officer | 437569 0.3743% | $5.88M | 1 | 20 | +9.77% |
| Shah Pritesh | Chief Growth Officer | 124511 0.1065% | $1.67M | 1 | 50 | +85.52% |
| MYLOD ROBERT J JR | director | 20000 0.0171% | $268,600.00 | 1 | 0 | <0.0001% |
| Danziger Asaf | Chief Executive Officer | 13583 0.0116% | $182,419.69 | 2 | 55 | <0.0001% |
| Increased Positions | 151 | +62.14% | 16M | +17.74% |
| Decreased Positions | 105 | -43.21% | 11M | -12.37% |
| New Positions | 50 | New | 2M | New |
| Sold Out Positions | 42 | Sold Out | 5M | Sold Out |
| Total Postitions | 289 | +18.93% | 96M | +5.37% |
| Fmr Llc | $220,021.00 | 14.97% | 16.77M | +47,123 | +0.28% | 2025-09-30 |
| Blackrock, Inc. | $182,992.00 | 12.45% | 13.95M | -166,926 | -1.18% | 2025-09-30 |
| Vanguard Group Inc | $137,181.00 | 9.34% | 10.46M | -296,555 | -2.76% | 2025-09-30 |
| Soleus Capital Management, L.P. | $126,541.00 | 8.61% | 9.64M | +3M | +39.69% | 2025-09-30 |
| State Street Corp | $34,252.00 | 2.33% | 2.61M | -67,384 | -2.52% | 2025-09-30 |
| Geode Capital Management, Llc | $32,472.00 | 2.21% | 2.47M | +30,552 | +1.25% | 2025-09-30 |
| Capital World Investors | $26,240.00 | 1.79% | 2M | -4M | -68.67% | 2025-09-30 |
| Nuveen, Llc | $22,407.00 | 1.53% | 1.71M | +681,404 | +66.39% | 2025-09-30 |
| Quantinno Capital Management Lp | $19,971.00 | 1.36% | 1.52M | +153,505 | +11.22% | 2025-09-30 |
| Millennium Management Llc | $17,522.00 | 1.19% | 1.34M | +688,710 | +106.48% | 2025-09-30 |